Search Results

You are looking at 1 - 1 of 1 items for :

  • Cell Biology x
Clear All
Open access

Hal E. Broxmeyer

There are three clinically used sources of hematopoietic stem cells (HSC) and hematopoietic progenitor cells (HPC) for hematopoietic cell transplantation (HCT): bone marrow (BM), umbilical cord blood (CB), and cytokine-induced mobilized peripheral blood (mPB) cells [ 1 , 2 , 3 , 4 , 5 ]. Each source of clinically used cells has its advantages and disadvantages. Of these, mPB cells make up the majority of autologous and allogeneic HCT efforts worldwide. The advantage of mPB is that one can, in many cases, usually collect more than enough cells to ensure a rapid